Edinburgh Research Explorer

MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)986-987
Number of pages2
JournalMultiple Sclerosis
Volume24
Publication statusPublished - 12 Oct 2018
Event34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - Berlin, Germany
Duration: 10 Oct 201812 Oct 2018

ID: 79615311